(a) Includes sales to nonconsolidated equity investees of $285 million and $835 million and $275 million and $793 million for the three and nine months ended October 1, 2017 and October 2, 2016, respectively.

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.